Literature DB >> 26215526

Accuracy of the Adverse Outcome Index: An Obstetrical Quality Measure.

Lisa M Foglia1, Peter E Nielsen, Eileen A Hemann, Suzan Walker, Jason A Pates, Peter G Napolitano, Shad Deering.   

Abstract

BACKGROUND: In obstetrics, a nationally accepted set of quality indicators for patient safety was not available in the United States until the development of a set of 10 adverse outcome measures-the Adverse Outcome Index (AOI). The National Perinatal Information Center (NPIC) developed hospital discharge data-based algorithms combined with a small set of supplemental patient data for calculation of the AOI. A study was conducted to determine the specificity, sensitivity, positive predictive value (PPV), and negative predictive value (NPV) of the AOI by using the National Perinatal Information Center (NPIC) algorithm.
METHODS: A retrospective chart review of 4,252 obstetrical and neonatal charts from 2003 through 2007 was performed. NPIC definitions were compared with the "gold standard"-chart review.
RESULTS: A total of 229 deliveries among the 4,000 randomly selected charts had at least one adverse outcome, reflecting an AOI of 5.7%. For detection of the 10 adverse outcomes within the AOI, the overall sensitivity of the AOI was 81.7%, specificity was 98.2%, PPV was 86.3%, and NPV was 97.4%. The Kappa value for agreement between the coded charts and the chart review was 0.82 (standard deviation=0.01, 95% confidence interval [CI]=0.80-0.85), which is considered very good. DISCUSSION: The AOI is highly reliant on accurate coding and provider documentation and requires validation with manual chart review. Concurrent chart review improves the accuracy of the AOI. Caution is advised when using the AOI as an exclusive measure of assessing obstetric quality because it may be heavily influenced by a single outcome measure; perineal laceration rates represented twice the frequency of all other outcomes combined. The AOI should be modified to better measure preventable adverse events and include a means of accounting for preexisting conditions.

Entities:  

Mesh:

Year:  2015        PMID: 26215526     DOI: 10.1016/s1553-7250(15)41048-7

Source DB:  PubMed          Journal:  Jt Comm J Qual Patient Saf        ISSN: 1553-7250


  5 in total

1.  Integrated Approach to Reduce Perinatal Adverse Events: Standardized Processes, Interdisciplinary Teamwork Training, and Performance Feedback.

Authors:  William Riley; James W Begun; Les Meredith; Kristi K Miller; Kathy Connolly; Rebecca Price; Janet H Muri; Mac McCullough; Stanley Davis
Journal:  Health Serv Res       Date:  2016-11-03       Impact factor: 3.402

2.  Association between weighted adverse outcome score and race/ethnicity in women and neonates.

Authors:  Saba H Berhie; Yvonne W Cheng; Aaron B Caughey; Lynn M Yee
Journal:  J Perinatol       Date:  2021-10-21       Impact factor: 2.521

3.  Birth outcomes following cesarean delivery on maternal request: a population-based cohort study.

Authors:  Yanfang Guo; Malia S Q Murphy; Erica Erwin; Romina Fakhraei; Daniel J Corsi; Ruth Rennicks White; Alysha L J Harvey; Laura M Gaudet; Mark C Walker; Shi Wu Wen; Darine El-Chaâr
Journal:  CMAJ       Date:  2021-05-03       Impact factor: 8.262

4.  Pregnancy outcomes in asylum seekers in the North of the Netherlands: a retrospective documentary analysis.

Authors:  A E H Verschuuren; I R Postma; Z M Riksen; R L Nott; E I Feijen-de Jong; J Stekelenburg
Journal:  BMC Pregnancy Childbirth       Date:  2020-05-25       Impact factor: 3.007

Review 5.  Testing cost containment of future healthcare with maintained or improved quality-The COSTCARES project.

Authors:  Karl Swedberg; Desmond Cawley; Inger Ekman; Heather L Rogers; Darijana Antonic; Daiga Behmane; Ida Björkman; Nicky Britten; Sandra C Buttigieg; Vivienne Byers; Mats Börjesson; Kirsten Corazzini; Andreas Fors; Bradi Granger; Boban Joksimoski; Roman Lewandowski; Virgilijus Sakalauskas; Einav Srulovici; Jan Törnell; Sara Wallström; Axel Wolf; Helen M Lloyd
Journal:  Health Sci Rep       Date:  2021-06-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.